Home › Hidradenitis Suppurativa › Alabama
Hidradenitis Suppurativa clinical trials in Alabama
7 studies for Hidradenitis Suppurativa are looking for participants at sites in Alabama.
Cities in Alabama
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- University of Alabama At Birmingham, Birmingham
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Nov 13, 2026 · NCT07213973Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US106, Birmingham
- Investigative Site US086, Birmingham
- Investigative Site US141, Birmingham
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06855498An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Total Skin and Beauty Dermatology Center PC, Birmingham
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Nov 9, 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Birmingham
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated Oct 29, 2026 · NCT07783542A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
- Site 117, Birmingham
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07766005Regulation of Inflammatory Genes in Hidradenitis Suppurativa
- Whitaker Clinic, Birmingham
RecruitingObservational study
Ages 18 to 89 · All sexes · Updated Sep 21, 2026 · NCT05507125Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
- University of Alabama at Birmingham, Birmingham
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06326476From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.